How should lung cancer pleural effusion be treated?

Pleural effusion of lung cancer is one of the common complications in the late stage of lung cancer, which is caused by lymph obstruction caused by cancer cells invading the pleura or cancer cells. Pleural effusion of lung cancer is growing rapidly, which is difficult to control and eliminate. A large amount of pleural effusion compresses the heart, lungs and mediastinum, which can cause discomfort such as chest tightness, shortness of breath and dyspnea, and seriously affect the quality of life of patients. Therefore, reducing or eliminating pleural effusion as soon as possible can effectively alleviate various symptoms caused by pleural effusion, thus improving the quality of life of patients. ..... so what? How to reduce or eliminate pleural effusion? Let's invite experts from xinqiao hospital Cancer Biotherapy Center to give us a detailed introduction. The most direct way to treat pleural effusion of lung cancer is to extract pleural effusion, and at the same time, we should pay attention to the amount of pleural effusion, which should not exceed 700ml for the first time and 1000ml every time. If you have a lot of pleural effusion, pump it 2-3 times a week. The purpose of pleural effusion in lung cancer is to help diagnosis and later symptomatic treatment. For patients with advanced lung cancer who have been diagnosed, thoracic decompression is the main method. Because excessive pleural effusion will lead to dyspnea in patients, pleural effusion should be removed from patients in time when treating pleural effusion in lung cancer. But as for when and how much to smoke, it depends on the growth rate of pleural effusion and the specific situation of patients, and there is no hard and fast rule in clinic. Although the treatment of lung cancer pleural effusion is the most direct treatment method, it is difficult to completely eliminate it because pleural effusion is easy to recur and often reappears after being pumped out once. In order to directly kill cancer cells and slow down the occurrence and development of pleural effusion in lung cancer, addictive drugs such as anticancer drugs, sclerosing agents and immunomodulators should be injected into the patient's chest while extracting pleural effusion. But at the same time, hydrothorax drugs for lung cancer can also cause pleural adhesion, which will do great harm to the patient's body, severely reduce the immunity, form a vicious circle, and the treatment effect is not ideal. Therefore, experts suggest that after the pleural effusion is extracted as much as possible, the combined biological immunotherapy scheme should be adopted to regulate human immune function, inhibit the abnormal proliferation of cancer cells, realize long-term "survival with tumor" and slow down the symptoms of pleural effusion in lung cancer. Biological immunotherapy is to extract immature immune cells, induce tumor-specific antigen sensitization through a series of cultures, so that their immune activity is greatly expanded, and mature immune cells are obtained and returned to patients, thus killing tumor cells, activating human anti-tumor immune response and inhibiting cancer cell proliferation. Biological immunotherapy (autologous cell immunotherapy) can effectively regulate human immune function, induce cancer cell differentiation, prevent tumor recurrence and metastasis, enhance patients' physique, enhance their independent anti-cancer ability, block the vicious circle of pleural effusion in lung cancer, and achieve the purpose of improving patients' quality of life and prolonging their survival time. Recommend Weibo Daxie Health official meager Xu infertility expert to re-treat Huang, the father of Chongqing IVF, and Huang Yong, director of cardiovascular surgery in the Second Affiliated Hospital.